Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
SAB Biotherapeutics Inc
About SABS
SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of human polyclonal immunotherapeutic antibodies, or human immunoglobulin G (hIgG), to address immunology disorders. The Company is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets or best-in-class against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. The Company’s lead product candidate, SAB-142, is a human anti-thymocyte globulin (ATG) focused on preventing or delaying the progression of T1D. SAB-142 is expected to reduce autoimmune beta cell destruction and delay progression or onset of T1D in patients with Stage III or Stage II T1D. The Company’s genetic engineering platform produces human, multi-targeted, high-potency immunoglobulins, without the need for human donors or convalescent plasma.
Find out what a historical investment in SAB Biotherapeutics Inc would be worth today using our SABS stock calculator.
Market Capitalisation
$302.80M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
404.1K
High today
$4.13
Low today
$3.85
Open price
$4.00
52-week high
$6.60
52-week low
$1.60
Ready to start your investing journey with Stake?
Open an accountHow do I buy SABS shares in Australia?
Buying SABS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in SAB Biotherapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SABS
What is the ticker symbol of SAB Biotherapeutics Inc?
The ticker symbol for SAB Biotherapeutics Inc is SABS.
How much is one share of SABS?
One share of SABS is valued at $3.87 as of 14 May 2026.
What is the market capitalisation of SAB Biotherapeutics Inc SABS?
As of 14 May 2026 SAB Biotherapeutics Inc has a market cap of $302.80M.
What is the 52-week high for SAB Biotherapeutics Inc stock?
The SAB Biotherapeutics Inc 52-week high stock price is $6.60.
What is the 52-week low for SAB Biotherapeutics Inc stock?
The SAB Biotherapeutics Inc 52-week low stock price is $1.60.
Can I buy SABS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SABS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SABS on Stake
- Buy SABS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of SABS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
SABS related stocks